Tumor cell microenvironment -- Toxin molecules -- Preparation and analysis of immunotoxins -- Efficacy of immunotoxins in experimental animal model systems -- Clinical trials -- New generation of immunotoxins: genetically engineered chimeric toxins -- Antiviral activity of RIP and targeting toxins to HIV-1 virus infected cells -- Future directions and prospects